Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. by Karl Ingard (22582091)

Subjects:

(A) PCA score scatter plots; (B)Heat map visualization of detected metabolites in PD and D phases; Various colors in the figure represent the relative content. by Bingshuo Shi (21485387)

Subjects:

Significant inter-relationships between baseline variables and MSCC or MCS. by Harshit Arora (22008280)

Subjects:

Mean muscle activation patterns across the gait cycle during walking with mediolateral (ML) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke duri... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... by Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with Body Weight Support (BWS) for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke dur... by Sanne Ettema (18786312)

Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo trypsinised with shades of green showing increase and red showing decrease with respect to soaked. by Indrani Bera (804948)

“…<p>Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…”

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

Subjects:

Forest plot depicting hazard ratios for the development of cardiovascular diseases. by Teng-Li Lin (5559284)

Subjects:

Forest plot depicting hazard ratios for the development of any cardiovascular diseases stratified by biologic classes, demographics, regions of data source, and comorbidities. by Teng-Li Lin (5559284)

Subjects:

Flow chart of the patient selection. by Teng-Li Lin (5559284)

Subjects:

Demographic characteristics of study subjects after PSM ^* . by Teng-Li Lin (5559284)

Subjects:

Cumulative incidence of any cardiovascular diseases in the BIO-cohort vs. the Non-BIO-cohort. by Teng-Li Lin (5559284)

Subjects:

CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset... by Lu Han (151620)

Subjects:

DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

“…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”

Cardiac performance and hemolymph distribution are significantly reduced upon valve malformation. by Christian Meyer (6035)

Autophagy significantly influences the apoptotic levels of RGCs in glaucomatous mouse eyes. by Hongmei Qian (538647)

Subjects:

Patient demographics. by Yongwoo Lee (2265172)

Subjects: